We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Higher Vitamin D Intake Needed to Reduce Cancer Risk

By LabMedica International staff writers
Posted on 09 Mar 2011
Researchers have reported that considerably higher intake of vitamin D is needed to reach blood levels that can prevent or significantly reduce the incidence of breast cancer and several other major diseases than had been previously believed. More...


The study's findings were published February 21, 2011, in the journal Anticancer Research. Investigators from the University of California, San Diego School of Medicine (UCSD; USA) and Creighton University School of Medicine (Omaha, NE, USA) conducted the research.

While these levels are higher than traditional intakes, they are largely in a range considered safe for daily use in a December 2010 report from the US National Academy of Sciences Institute of Medicine (Washington DC, USA;). "We found that daily intakes of vitamin D by adults in the range of 4,000 IU to 8,000 IU are needed to maintain blood levels of vitamin D metabolites in the range needed to reduce by about half the risk of several diseases--breast cancer, colon cancer, multiple sclerosis, and type 1 diabetes,” said Cedric Garland, DrPH, professor of family and preventive medicine at UC San Diego Moores Cancer Center. "I was surprised to find that the intakes required to maintain vitamin D status for disease prevention were so high--much higher than the minimal intake of vitamin D of 400 IU/day that was needed to defeat rickets in the 20th century.”

"I was not surprised by this,” said Robert P. Heaney, MD, of Creighton University, a biomedical scientist who has studied vitamin D need for several decades. "This result was what our dose-response studies predicted, but it took a study such as this, of people leading their everyday lives, to confirm it.”

The study reported on a survey of several thousand volunteers who were taking vitamin D supplements in the dosage range from 1,000 IU/day to 10,000 IU/day. Blood studies were conducted to determine the level of 25-vitamin D--the form in which nearly all vitamin D circulates in the blood.

"Most scientists who are actively working with vitamin D now believe that 40 ng/mL to 60 ng/mL is the appropriate target concentration of 25-vitamin D in the blood for preventing the major vitamin D-deficiency related diseases, and have joined in a letter on this topic,” said Garland. "Unfortunately, according a recent National Health and Nutrition Examination Survey, only 10% of the US population has levels in this range, mainly people who work outdoors.”

Interest in larger doses was spurred in December 2010, when a National Academy of Sciences Institute of Medicine committee identified 4,000 IU/day of vitamin D as safe for everyday use by adults and children nine years and older, with intakes in the range of 1,000 IU/day to 3,000 IU/day for infants and children through age eight years old.

While the IOM committee stated that 4,000 IU/day is a safe dosage, the recommended minimum daily intake is only 600 IU/day. "Now that the results of this study are in, it will become common for almost every adult to take 4,000 IU/day,” Dr. Garland said. "This is comfortably under the 10,000 IU/day that the IOM Committee Report considers as the lower limit of risk, and the benefits are substantial.” He added that individuals who may have contraindications should discuss their vitamin D needs with their family physician.

"Now is the time for virtually everyone to take more vitamin D to help prevent some major types of cancer, several other serious illnesses, and fractures,” concluded Dr. Heaney.

Related Links:

University of California, San Diego School of Medicine
Creighton University School of Medicine



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.